Pharmacotherapy and the risk for community-acquired pneumonia

BMC Geriatrics

Volumn 10, Issue , 2010, Pages

  Gau, Jen Tzer ^a   Acharya, Utkarsh ^b   Khan, Salman ^c   Heh, Victor ^a   Mody, Lona ^d   Kao, Tzu Cheg ^e  

^a OHIO UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NEUROLEPTIC AGENT; PROTON PUMP INHIBITOR;

AGED; ARTICLE; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COMMUNICABLE DISEASE; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MALE; PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICS; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; AGED; AGED, 80 AND OVER; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HOSPITALIZATION; HUMANS; MALE; PNEUMONIA; PROTON PUMP INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 77955013747     PISSN: None     EISSN: 14712318     Source Type: Journal    
DOI: 10.1186/1471-2318-10-45     Document Type: Article

References (32)

1. Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. AM Fry DK Shay RC Holman AT Curns LJ Anderson, JAMA 2005 294 2712 2719 10.1001/jama.294.21.2712 16333006
2. Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance study in Ohio. The community-based pneumonia incidence study group. RE Guevara JC Butler BJ Marston JF Plouffe TM File Jr RF Breiman, Arch Intern Med 1997 157 1709 1718 10.1001/archinte.157.15.1709 9250232
3. The latest: Trends in pneumonia and influenza morbidity and mortality. Data & Statistics, American Lung Association (online) 2008 http://www.lungusa.org
4. Risk factors for community-acquired pneumonia diagnosed upon hospital admission. British Thoracic Society Pneumonia Study Group. BM Farr CL Bartlett J Wadsworth DL Miller, Respir Med 2000 94 954 963 10.1053/rmed.2000.0865 11059948
5. Risk factors for community-acquired pneumonia diagnosed by general practitioners in the community. BM Farr MA Woodhead JT Macfarlane CL Bartlett JS McCraken J Wadsworth DL Miller, Respir Med 2000 94 422 427 10.1053/rmed.1999. 0743 10868703
6. The burden of community-acquired pneumonia in seniors: results of a population-based study. ML Jackson KM Neuzil WW Thompson DK Shay O Yu CA Hanson LA Jackson, Clin Infect Dis 2004 39 1642 1650 10.1086/425615 15578365
7. Risk factors for community-acquired pneumonia in adults: a population-based case-control study. J Almirall I Bolíbar X Balanzá CA Gonzlez, Eur Respir J 1999 13 349 355 10.1183/09031936.99. 13234999 10065680
8. Proportion of community-acquired pneumonia cases attributable to tobacco smoking. J Almirall CA Gonzlez X Balanzá I Bolíbar, Chest 1999 116 375 379 10.1378/chest.116.2.375 10453865
9. A prospective study of age and lifestyle factors in relation to community-acquired pneumonia in US men and women. I Baik GC Curhan EB Rimm A Bendich WC Willett WW Fawzi, Arch Intern Med 2000 160 3082 3088 10.1001/archinte.160.20.3082 11074737
10. Prospective study of pneumonia hospitalizations and mortality of U.S. older people: the role of chronic conditions, health behaviors, and nutritional status. AZ LaCroix S Lipson TP Miles L White, Public Health Rep 1989 104 350 360 2502806
11. Factors of importance for the long term prognosis after hospital treated pneumonia. JU Hedlund AB Ortqvist ME Kalin F Granath, Thorax 1993 48 785 789 10.1136/thx.48.8.785 8211867
12. Community-acquired pneumonia in the elderly: A multivariate analysis of risk and prognostic factors. R Riquelme A Torres M El-Ebiary JP de la Bellacasa R Estruch J Mensa J Fernndez-Sol C Hernndez R Rodriguez-Roisin, Am J Respir Crit Care Med 1996 154 1450 1455 8912763
13. Low levels of serum cholesterol and albumin and the risk of community-acquired pneumonia in young soldiers. DR Kang YK Kim MS Park YS Kim DH Ko C Kim, Int J Tuberc Lung Dis 2008 12 26 32 18173873
14. Antipsychotic drug use and risk of pneumonia in elderly people. W Knol RJ van Marum PA Jansen PC Souverein AF Schobben AC Egberts, J Am Geriatr Soc 2008 56 661 666 10.1111/j.1532-5415.2007.01625.x 18266664
15. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. RJ Laheij MC Sturkenboom RJ Hassing J Dieleman BH Stricker JB Jansen, JAMA 2004 292 1955 1960 10.1001/jama.292.16.1955 15507580
16. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. SE Gulmez A Holm H Frederiksen TG Jensen C Pedersen J Hallas, Arch Intern Med 2007 167 950 955 10.1001/archinte.167.9.950 17502537
17. Risk of community-acquired pneumonia and the use of statins, ace inhibitors and gastric acid suppressants: a population-based case-control study. PR Myles RB Hubbard TM McKeever Z Pogson CJ Smith JE Gibson, Pharmacoepidemiol Drug Saf 2009 18 269 275 10.1002/pds.1715 19235776
18. Acid-suppressive medication use and the risk for hospital-acquired pneumonia. SJ Herzig MD Howell LH Ngo ER Marcantonio, JAMA 2009 301 2120 2128 10.1001/jama.2009.722 19470989
19. Proton-pump inhibitor use and the risk for community-acquired pneumonia. M Sarkar S Hennessy YX Yang, Ann Intern Med 2008 149 391 398 18794558
20. Association between proton pump inhibitors and respiratory infections: a systematic review and meta-analysis of clinical trials. N Sultan J Nazareno J Gregor, Can J Gastroenterol 2008 22 761 766 18818790
21. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. P Ernst AV Gonzalez P Brassard S Suissa, Am J Respir Crit Care Med 2007 176 162 166 10.1164/rccm.200611-1630OC 17400730
22. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. PM Calverley JA Anderson B Celli GT Ferguson C Jenkins PW Jones JC Yates J Vestbo TORCH investigators, N Engl J Med 2007 356 775 789 10.1056/NEJMoa063070 17314337
23. Impact of Salmeterol/fluticasone propionate versus salmeterol on exacerbations in severe chronic obstructive pulmonary disease. P Kardos M Wencker T Glaab C Vogelmeier, Am J Respir Crit Care Med 2007 175 144 149 10.1164/rccm.200602-244OC 17053207
24. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. MB Drummond EC Dasenbrook MW Pitz DJ Murphy E Fan, JAMA 2008 300 2407 2416 10.1001/jama.2008. 717 19033591
25. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. S Singh AV Amin YK Loke, Arch Intern Med 2009 169 219 229 10.1001/archinternmed.2008.550 19204211
26. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. IA Yang KM Fong EH Sim PN Black TJ Lasserson, Cochrane Database Syst Rev 2007 2 D002991 17443520
27. Accuracy of diagnostic registers and management of chronic obstructive pulmonary disease: the Devon primary care audit. RC Jones M Dickson-Spillmann MJ Mather D Marks BS Shackell, Respir Res 2008 9 62 10.1186/1465-9921-9-62 18710575
28. Esophageal dysfunction on psychotropic medication. A case report and literature review. AS Maddalena M Fox M Hofmann C Hock, Pharmacopsychiatry 2004 37 134 138 10.1055/s-2004-818993 15138897
29. Systematic review: the epidemiology of gastro-oesophageal reflux disease in primary care, using the UK General Practice Research Database. H El-Serag C Hill R Jones, Aliment Pharmacol Ther 2009 29 470 480 10.1111/j.1365-2036.2008. 03901.x 19035977
30. Uses of proton pump inhibitors and serum potassium levels. JT Gau V Heh U Acharya YX Yang TC Kao, Pharmacoepidemiol Drug Saf 2009 18 865 871 10.1002/pds.1795 19557730
31. Impact of gastro-oesophageal reflux disease symptoms on COPD exacerbation. K Terada S Muro S Sato T Ohara A Haruna S Marumo D Kinose E Ogawa Y Hoshino A Niimi T Terada M Mishima, Thorax 2008 63 951 955 10.1136/thx.2007.092858 18535116
32. Role of gastroesophageal reflux symptoms in exacerbations of COPD. IE Rascon-Aguilar M Pamer P Wludyka J Cury D Coultas LR Lambiase NS Nahman KJ Vega, Chest 2006 130 1096 1101 10.1378/chest.130.4.1096 17035443